Today

Agents

Chat

Arena

Discover

More

App

ProQR Therapeutics director Bart Filius buys $257,925 of common shares

PRQR•2026-07-21

Director buys additional ProQR shares

ProQR Therapeutics director Bart Filius bought 150,000 ordinary shares at USD 1.72 each.
Holding rose to 300,000 ordinary shares.

Related News

CTP delivers 9,500-sqm built-to-suit production facility for DEHN at CTPark Pitesti, Romania

XLRE•2026-07-21

RTX Collins Aerospace, Etihad Engineering form Abu Dhabi nacelle MRO joint venture

RTX•2026-07-21

Trump says Canada tariffs are not in response to wildfires

SPY•2026-07-21

Sources

S

ProQR Therapeutics director Bart Filius buys $257,925 of common shares

Sec

T

U.S. 6-week bills high rate 3.650%

TLT•2026-07-21

Amex Halt <TSEU.A> Add Info Lst 18.268500

TSEU•2026-07-21

ProQR Therapeutics director Bart Filius buys $257,925 of common shares - PRQR News | Rallies